Another U.S. congressman is putting pressure on the Drug Enforcement Administration (DEA) to follow through on a presidential request regarding cannabis reform. Rep. Steve Cohen, D-Tenn., wrote a letter Jan. 4 to DEA Administrator Anne Milgram urging her “in the strongest possible way” to act expeditiously on the Aug. 29 Department of Health and Human Services … [Read more...] about US Congressman Urges DEA to Expedite Rescheduling Cannabis
DEA
DEA Notice Shows Increase in Research Amounts for THC, Psilocybin, DMT, and More
The Drug Enforcement Agency (DEA) posted a notice on the Federal Register on Jan. 3, which includes the most recent breakdown of Schedule I Substances in its 2024 aggregate production quotas (APQ), as well as a wide variety of public comments and DEA responses. According to a Federal Register article published in November 2023, delta-9 THC (referred to as “d-9-THC” on the list) … [Read more...] about DEA Notice Shows Increase in Research Amounts for THC, Psilocybin, DMT, and More
Former US Attorneys Urge Federal Officials to Reject Cannabis Rescheduling Recommendation
The Dec. 13 letter, addressed to U.S. Attorney General Merrick Garland and Drug Enforcement Administration (DEA) Administrator Anne Milgram and signed by 29 former attorneys, comes in response to the U.S. Health and Human Services’ (HHS) August recommendation that cannabis be reclassified under the Controlled Substances Act (CSA). HHS still has not confirmed publicly the … [Read more...] about Former US Attorneys Urge Federal Officials to Reject Cannabis Rescheduling Recommendation
DEA warns Georgia to cancel plans to become first state to allow pharmacies to sell medical marijuana
The U.S. Drug Enforcement Administration is warning Georgia not to move forward with its plan to become the first state to allow pharmacies to distribute medical marijuana. DEA officials told pharmacies that dispensing medical marijuana would violate federal law. The Georgia Access to Medical Cannabis Commission, which oversees the state's medical marijuana industry, said it … [Read more...] about DEA warns Georgia to cancel plans to become first state to allow pharmacies to sell medical marijuana
DEA Warns Georgia Pharmacies To Stop Selling Low-THC Cannabis Oil
Federal law enforcement agents sent a warning letter dated Nov. 27 to pharmacies across Georgia, warning them that dispensing and selling cannabis oil is illegal under federal law. The letter arrived a month into Georgia’s medical cannabis program. Last June, Georgia’s Board of Pharmacy released a set of regulations that enable the state’s independent pharmacies to dispense … [Read more...] about DEA Warns Georgia Pharmacies To Stop Selling Low-THC Cannabis Oil
Blunts: Congress’ Research Says Keep Weed Taxes Low
Earlier this month, the Congressional Research Service (CRS) released a report that recommended low federal cannabis taxes to avoid unfair pressure on the industry. According to the report, cannabis advocates who claim that legalizing the drug would provide a new tax revenue source for the government may not be considering the potential economic impact of overburdensome taxes … [Read more...] about Blunts: Congress’ Research Says Keep Weed Taxes Low
How this proposed change could dramatically shift U.S. marijuana policy
The Biden administration is considering a major shift in the federal government’s policy on marijuana. In late August, the Department of Health and Human Services recommended that the Drug Enforcement Administration reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act. The Food and Drug Administration has also concluded that marijuana should … [Read more...] about How this proposed change could dramatically shift U.S. marijuana policy
Congressional Report Predicts DEA ‘Likely’ To Approve Marijuana Reclassification
The Drug Enforcement Administration is “likely” to approve a recommendation from the Biden administration to reclassify marijuana under the nation’s drug laws, according to a report issued by congressional researchers this week. The report, which was released by the Congressional Research Service (CRS) on Wednesday, comes after a recommendation from the Department of Health and … [Read more...] about Congressional Report Predicts DEA ‘Likely’ To Approve Marijuana Reclassification
DEA Doubles Down on Decision To Fire Agent Who Tried To Replace Opioids With CBD
The Drug Enforcement Administration recently defended their decision to fire an “outstanding” special agent fired earlier this year for using CBD oil to replace his pain medication, a decision which caused him to test positive for cannabis on a drug test. According to court documents, Special Agent Anthony Armour filed a wrongful termination lawsuit in May of this year against … [Read more...] about DEA Doubles Down on Decision To Fire Agent Who Tried To Replace Opioids With CBD
Marijuana laws could change as DEA considers reclassification
The federal government first classified cannabis as a Schedule I drug back in 1970 with the Controlled Substances Act. For years, it sat alongside heroin on the same list under federal law. Now, the Drug Enforcement Administration, the DEA, has a big decision to make: Do they keep cannabis as a Schedule I drug or do they change it? Not the first time The decision is now in the … [Read more...] about Marijuana laws could change as DEA considers reclassification
